Amphenol falls 3% as risk-off sentiment and profit-taking weigh on richly valued shares

Amphenol Corporation (APH) is down 3.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop looks most consistent with a broader “risk-off” tape, with investors de-risking equities amid renewed uncertainty around the Iran ceasefire and higher oil prices, which can pressure high-multiple industrial/tech names. Given Amphenol’s sharp run-up earlier in April, the move also appears to include profit-taking and valuation sensitivity rather than company-specific bad news.

Details:

U.S. stocks turned lower as uncertainty increased around the durability of the Iran ceasefire, while oil prices fluctuated higher on the headlines, weighing on overall risk appetite.

Amphenol had already posted a strong April advance and traded at a premium valuation versus its peer group, making the stock more prone to pullbacks when sentiment shifts.

The company’s most recently issued outlook (from its latest reported quarter) pointed to continued growth but also highlighted acquisition-related costs tied to the CommScope CCS transaction, which can keep investors focused on near-term execution and integration risk.

With the next earnings report approaching, some investors may be reducing exposure ahead of the event, which can amplify routine down days.

Sources:

Associated Press, AAII, Amphenol Investor Relations

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$APH Insider Trading Activity

$APH insiders have traded $APH stock on the open market 12 times in the past 6 months. Of those trades, 1 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:

LUC WALTER (President, HES Division) has made 0 purchases and 2 sales selling 365,118 shares for an estimated $49,163,430.
CRAIG A LAMPO (SR VP & CFO) has made 0 purchases and 2 sales selling 298,076 shares for an estimated $42,697,133.
MICHAEL R. IVAS (VP & Corporate Controller) has made 0 purchases and 2 sales selling 240,000 shares for an estimated $33,762,588.
WILLIAM J DOHERTY (President, CS Division) has made 0 purchases and 2 sales selling 160,000 shares for an estimated $22,643,160.
PETER STRAUB (President, ISS Division) sold 132,000 shares for an estimated $18,722,840
DAVID M SILVERMAN (Senior VP, Human Resources) sold 120,000 shares for an estimated $16,940,472
LANCE E D'AMICO (Sr. VP, Secretary & GenCounsel) sold 120,000 shares for an estimated $16,801,548
ROBERT LIVINGSTON purchased 10,000 shares for an estimated $1,285,080

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EARLY ACCESS

Receive APH Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$APH Hedge Fund Activity

We have seen 1,008 institutional investors add shares of $APH stock to their portfolio, and 863 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP added 75,964,718 shares (+9435.8%) to their portfolio in Q4 2025, for an estimated $10,265,871,990
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 23,934,785 shares (-74.1%) from their portfolio in Q4 2025, for an estimated $3,234,546,844
JPMORGAN CHASE & CO added 17,391,036 shares (+102.7%) to their portfolio in Q4 2025, for an estimated $2,350,224,605
FMR LLC removed 13,395,833 shares (-13.4%) from their portfolio in Q4 2025, for an estimated $1,810,312,871
JENNISON ASSOCIATES LLC added 7,930,532 shares (+340.8%) to their portfolio in Q4 2025, for an estimated $1,071,732,094
BANK OF NEW YORK MELLON CORP removed 6,290,275 shares (-26.2%) from their portfolio in Q4 2025, for an estimated $850,067,763
PRICE T ROWE ASSOCIATES INC /MD/ removed 6,148,762 shares (-14.0%) from their portfolio in Q4 2025, for an estimated $830,943,696

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APH Analyst Ratings

Wall Street analysts have issued reports on $APH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citigroup issued a "Buy" rating on 01/12/2026

To track analyst ratings and price targets for $APH, check out Quiver Quantitative's $APH forecast page.

$APH Price Targets

Multiple analysts have issued price targets for $APH recently. We have seen 6 analysts offer price targets for $APH in the last 6 months, with a median target of $177.5.

Here are some recent targets:

Samik Chatterjee from JP Morgan set a target price of $190.0 on 04/16/2026
Joseph Spak from UBS set a target price of $170.0 on 04/14/2026
Stephen Volkmann from Jefferies set a target price of $145.0 on 03/31/2026
Guy Hardwick from Barclays set a target price of $175.0 on 01/29/2026
Asiya Merchant from Citigroup set a target price of $180.0 on 01/29/2026
William Stein from Truist Securities set a target price of $180.0 on 12/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.